Want to join the conversation?
Diverse derivatives marketplace $CME's 3Q15 earnings rose 23% to $1.06 per diluted share and net income rose 24% to $360MM compared to a year ago. Its revenues rose 11% to $850.3MM YoverY. The results reflect revenue growth in commodity products by 14%, financial products were up 10%, and market data revenue rose 13%.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.